Cargando…
Effects of Renin‐Angiotensin–Aldosterone System Inhibitors on Long‐Term Major Adverse Cardiovascular Events in Sepsis Survivors
BACKGROUND: Sepsis is known to increase morbidity and duration of hospital stay and is a common cause of mortality worldwide. Renin‐angiotensin‐aldosterone system inhibitors (RAASis) are commonly used to treat hypertension but are usually discontinued during hospitalization for sepsis because of con...
Autores principales: | Ou, Shu‐Yu, Lee, Yi‐Jung, Lo, Yuan, Chen, Chen‐Hsiu, Huang, Yu‐Chi, Kuo, Yu‐Ting, Chia, Yuan‐Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075354/ https://www.ncbi.nlm.nih.gov/pubmed/34845916 http://dx.doi.org/10.1161/JAHA.121.022870 |
Ejemplares similares
-
The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
por: Zheng, Ming-Hui, et al.
Publicado: (2020) -
Association of Genetic Polymorphisms of Renin–Angiotensin–Aldosterone System-Related Genes with Arterio-Venous Fistula Malfunction in Hemodialysis Patients
por: Chen, Yu-Wei, et al.
Publicado: (2016) -
Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020) -
Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012) -
Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)